MENU
INVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Innoviva (INVA) Ownership - Who owns Innoviva?

Profile

Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.15B
P/E Ratio
22.96
Total Cash
N/A
Projected Growth
N/A
Total Debt
449.33M
Revenue
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
5.15 USD as % of share price

Fundamentals

INVA
Capitalization
1.15B
P/E Ratio
22.96
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
449M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.15%
Revenue
N/A
ROE
N/A
Book Value
704M
P/B Ratio
1.72
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
628K
Current Ratio
10.42
Current Revenue Per Employee
691955.40
Dividends Per Share - Security
0.00
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
85.84
Revenue To Assets
N/A
Shares Held By Institutions
1.78B
Shares Outstanding - Current
62.6M
Total Liabilities
211M
Total Volume MTD
N/A
Value
N/A
Gain YTD
14.526
View a ticker or compare two or three
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com